Literature DB >> 28332894

Incidence and Progression of Diabetic Retinopathy in Urban India: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), Report 1.

Rajiv Raman1, Suganeswari Ganesan1, Swakshyar Saumya Pal1, Laxmi Gella1,2, Vaitheeswaran Kulothungan3, Tarun Sharma1.   

Abstract

PURPOSE: To evaluate the 4-year incidence and progression of and risk factors for diabetic retinopathy (DR) in an Indian population.
METHODS: From a cross-sectional study of 1425 subjects with diabetes, 911 (63.9%) returned for 4-year follow-up. After excluding 21 with ungradable retinal images, data from 890 subjects were analyzed. Participants underwent examinations based on a standard protocol, which included grading of retinal photographs.
RESULTS: The incidences of DR, diabetic macular edema (DME), and sight-threatening diabetic retinopathy (STDR) were 9.2%, 2.6%, and 5.0%, respectively. In subjects with DR at baseline, the incidence of DME and STDR had increased (11.5% and 22.7%, respectively). 1-step and 2-step progressions of DR were seen in 30.2% and 12.6% of participants, respectively, and 1-step and 2-step regressions were seen in 12.0% and 1.8%, respectively. Incident DR, DME, and STDR were associated with higher systolic blood pressure (odds ratio, OR, 1.21, 2.11 and 1.72, respectively, for every 10 mmHg increase). Incident DR and DME were associated with increasing duration of diabetes (OR 2.29 and 4.77, respectively, for every 10-year increase) and presence of anemia (OR 1.96 and 10.14, respectively). Incident DR was also associated with higher hemoglobin A1c (OR 1.16 for every 1% increase). Variables associated with 1-step progression were every 10 mg/dL increase in serum total cholesterol (OR 15.65) as a risk factor, and 10 mg/dL increase in serum triglyceride (OR 0.52) as a protective factor.
CONCLUSIONS: The incidences of STDR and DME were higher in people with pre-existing DR than in those without DR at baseline.

Entities:  

Keywords:  Diabetic retinopathy; incidence; progression; regression; risk factors

Mesh:

Substances:

Year:  2017        PMID: 28332894     DOI: 10.1080/09286586.2017.1290257

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  23 in total

1.  Correlating the patterns of diabetic macular edema, optical coherence tomography biomarkers and grade of diabetic retinopathy with stage of renal disease.

Authors:  Manisha Agarwal; Mani Sachdeva; Shalin Shah; Rajiv Raman; Padmaja K Rani; Ramachandran Rajalakshmi; Sobha Sivaprasad; T P Vignesh; Kim Ramasamy; Aishwarya Madharia; Alok Sen; Shalini Sugumar; Umesh Chandra Behera; Ann Maria Rodrigues; Giridhar Anantharaman; Swati Priya; Atanu Majumdar
Journal:  Int Ophthalmol       Date:  2022-05-28       Impact factor: 2.029

2.  Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia.

Authors:  Sezaneh Haghpanah; Omid Reza Zekavat; Sanaz Safaei; Mohammad Ali Ashraf; Shirin Parand; Hossein Ashraf
Journal:  BMC Ophthalmol       Date:  2022-06-24       Impact factor: 2.086

Review 3.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

4.  Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes.

Authors:  William S Gange; Jennifer Lopez; Benjamin Y Xu; Khristina Lung; Seth A Seabury; Brian C Toy
Journal:  Diabetes Care       Date:  2021-09-02       Impact factor: 19.112

5.  Effectiveness of Teleretinal Imaging-Based Hospital Referral Compared With Universal Referral in Identifying Diabetic Retinopathy: A Cluster Randomized Clinical Trial.

Authors:  Sanil Joseph; Ramasamy Kim; Ravilla D Ravindran; Astrid E Fletcher; Thulasiraj D Ravilla
Journal:  JAMA Ophthalmol       Date:  2019-07-01       Impact factor: 7.389

6.  MicroRNA‑4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells.

Authors:  Li Jing; Hong Li; Tao Zhang; Jianxin Lu; Lianjin Zhong
Journal:  Mol Med Rep       Date:  2019-03-01       Impact factor: 2.952

7.  Sirtuin (Sirt) 3 Overexpression Prevents Retinopathy in Streptozotocin-Induced Diabetic Rats.

Authors:  Xin-Bang Mao; Yan-Hua Cheng; Ke-Su Peng; Zhi-Peng You
Journal:  Med Sci Monit       Date:  2020-05-27

Review 8.  Prevalence, Incidence and Ecological Determinants of Diabetic Retinopathy in Iran: Systematic Review and Meta-analysis.

Authors:  Golnoush Sadat Mahmoudi Nezhad; Reza Razeghinejad; Mohsen Janghorbani; Alireza Mohamadian; Mohammad Hassan Jalalpour; Somaye Bazdar; Alireza Salehi; Hossein Molavi Vardanjani
Journal:  J Ophthalmic Vis Res       Date:  2019-07-18

9.  Tackling diabetic retinopathy from the grassroots.

Authors:  Sobha Sivaprasad
Journal:  Indian J Ophthalmol       Date:  2020-02       Impact factor: 1.848

10.  The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals.

Authors:  Sultan F Magliah; Wedad Bardisi; Maha Al Attah; Manal M Khorsheed
Journal:  J Family Med Prim Care       Date:  2018 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.